Forte Biosciences
Launch date
Employees
Market cap
€9.7m
Enterprise valuation
(€13m) (Public information from Sep 2024)
Share price
$7.005 FBRX
Los Angeles California (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | - | - | 9.0m |
| EBITDA | 17.9m | (21.4m) | (13.9m) | (32.5m) | - | - | - |
| Profit | (46.5m) | (21.7m) | (13.9m) | (31.5m) | - | - | - |
| EV / revenue | - | - | - | - | - | - | 1.3x |
| EV / EBITDA | 22.8x | -1.5x | -1.5x | -0.9x | - | - | - |
| R&D budget | 10.0m | 13.9m | 5.6m | 21.9m | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | $5.8m | Early VC | |
* | N/A | $40.0m | Post IPO Equity |
* | $25.0m | Post IPO Debt | |
| Total Funding | €5.3m | ||